Individualizing Your Patient's A1c Target

Determine a patient-specific A1C target recommendation

About

This tool was developed based on the 2018 Diabetes Canada Clinical Practice Guidelines for the Prevention and Management of Diabetes. Published every five years, these guidelines represent the best and most current evidence-based clinical practice data for healthcare professionals.

Optimal glycemic control is fundamental to the management of diabetes. In most people with type 1 or type 2 diabetes, Diabetes Canada recommends targeting an A1c ≤7.0% to reduce the risk of vascular complications. In people with type 2 diabetes, an A1c ≤6.5% may be targeted to reduce the risk of chronic kidney disease and retinopathy, if they are assessed to be at low risk of hypoglycemia (based on class of antihyperglycemic medication(s) utilized and the person's characteristics). A higher A1c target may be considered in people with the goals of avoiding hypoglycemia and over-treatment related to antihyperglycemic therapy, with any of the following:

  • 1. Functionally dependent: 7.1 ‐ 8.0%
  • 2. Recurrent severe hypoglycemia and/or hypoglycemia unawareness: 7.1 ‐ 8.5%
  • 3. Limited life expectancy: 7.1 ‐ 8.5%
  • 4. Frail and/or with dementia: 7.1 ‐ 8.5%
  • 5. End of life: A1c measurement not recommended. Avoid symptomatic hyperglycemia and any hypoglycemia.

References

Berard, Lori D., et al.

Canadian Journal of Diabetes 2018, 42 Suppl 1: S47-S53

Imran, S. Ali, et al.

Canadian Journal of Diabetes 2018, 42 Suppl 1: S42-S46

The Individualizing Your Patient's A1c Target calculator is created by QxMD.
Default Units

1. Age?

0/7 completed

About

This tool was developed based on the 2018 Diabetes Canada Clinical Practice Guidelines for the Prevention and Management of Diabetes. Published every five years, these guidelines represent the best and most current evidence-based clinical practice data for healthcare professionals.

Optimal glycemic control is fundamental to the management of diabetes. In most people with type 1 or type 2 diabetes, Diabetes Canada recommends targeting an A1c ≤7.0% to reduce the risk of vascular complications. In people with type 2 diabetes, an A1c ≤6.5% may be targeted to reduce the risk of chronic kidney disease and retinopathy, if they are assessed to be at low risk of hypoglycemia (based on class of antihyperglycemic medication(s) utilized and the person's characteristics). A higher A1c target may be considered in people with the goals of avoiding hypoglycemia and over-treatment related to antihyperglycemic therapy, with any of the following:

  • 1. Functionally dependent: 7.1 ‐ 8.0%
  • 2. Recurrent severe hypoglycemia and/or hypoglycemia unawareness: 7.1 ‐ 8.5%
  • 3. Limited life expectancy: 7.1 ‐ 8.5%
  • 4. Frail and/or with dementia: 7.1 ‐ 8.5%
  • 5. End of life: A1c measurement not recommended. Avoid symptomatic hyperglycemia and any hypoglycemia.

References

Berard, Lori D., et al.

Canadian Journal of Diabetes 2018, 42 Suppl 1: S47-S53

Imran, S. Ali, et al.

Canadian Journal of Diabetes 2018, 42 Suppl 1: S42-S46

The Individualizing Your Patient's A1c Target calculator is created by QxMD.
Contributed By:
  • Benjamin Mammon, MD Candidate
Legal Notices and Disclaimer

© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.